[go: up one dir, main page]

NO20035038D0 - Forhindring av avhengighet ved smertebehandling - Google Patents

Forhindring av avhengighet ved smertebehandling

Info

Publication number
NO20035038D0
NO20035038D0 NO20035038A NO20035038A NO20035038D0 NO 20035038 D0 NO20035038 D0 NO 20035038D0 NO 20035038 A NO20035038 A NO 20035038A NO 20035038 A NO20035038 A NO 20035038A NO 20035038 D0 NO20035038 D0 NO 20035038D0
Authority
NO
Norway
Prior art keywords
addiction
prevention
pain management
eliminating
reducing
Prior art date
Application number
NO20035038A
Other languages
English (en)
Other versions
NO331509B1 (no
Inventor
Stephen L Dewey
Jr Charles R Ashby
Original Assignee
Brookhaven Science Ass Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Brookhaven Science Ass Llc filed Critical Brookhaven Science Ass Llc
Publication of NO20035038D0 publication Critical patent/NO20035038D0/no
Publication of NO331509B1 publication Critical patent/NO331509B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36—Opioid-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Addiction (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Rheumatology (AREA)
  • Toxicology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO20035038A 2001-05-14 2003-11-13 Anvendelse av gammavinyl-GABA for fremstilling av et farmasoytisk preparat for anvendelse ved behandling av smerte i en vert NO331509B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/853,548 US20020187996A1 (en) 2001-05-14 2001-05-14 Prevention of addiction in pain management
PCT/US2002/011072 WO2002091990A2 (en) 2001-05-14 2002-04-08 Prevention of addiction in pain management

Publications (2)

Publication Number Publication Date
NO20035038D0 true NO20035038D0 (no) 2003-11-13
NO331509B1 NO331509B1 (no) 2012-01-16

Family

ID=25316324

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20035038A NO331509B1 (no) 2001-05-14 2003-11-13 Anvendelse av gammavinyl-GABA for fremstilling av et farmasoytisk preparat for anvendelse ved behandling av smerte i en vert

Country Status (21)

Country Link
US (3) US20020187996A1 (no)
EP (1) EP1392301B1 (no)
JP (1) JP2004534029A (no)
KR (1) KR20040020054A (no)
CN (1) CN100528156C (no)
AT (1) ATE473001T1 (no)
AU (1) AU2002342533B2 (no)
BR (1) BR0209613A (no)
CA (1) CA2446639C (no)
CZ (1) CZ20033380A3 (no)
DE (1) DE60236927D1 (no)
ES (1) ES2348637T3 (no)
HR (1) HRP20030892A2 (no)
HU (1) HUP0402326A3 (no)
IL (1) IL158762A0 (no)
MX (1) MXPA03010407A (no)
NO (1) NO331509B1 (no)
NZ (1) NZ529614A (no)
PL (1) PL368505A1 (no)
WO (1) WO2002091990A2 (no)
YU (1) YU89003A (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2302742T5 (es) * 2000-07-31 2011-10-10 Nycomed Danmark Aps Pulverizador nasal para suministrar una composición farmacéutica.
DE10141650C1 (de) 2001-08-24 2002-11-28 Lohmann Therapie Syst Lts Transdermales Therapeutisches System mit Fentanyl bzw. verwandten Substanzen
US20050043345A1 (en) * 2003-08-22 2005-02-24 Pfizer Inc Pharmaceutical composition for the prevention and treatment of addiction in a mammal
US8652527B1 (en) 2013-03-13 2014-02-18 Upsher-Smith Laboratories, Inc Extended-release topiramate capsules
US9101545B2 (en) 2013-03-15 2015-08-11 Upsher-Smith Laboratories, Inc. Extended-release topiramate capsules
CN105497896A (zh) * 2015-03-31 2016-04-20 苏州大学 一种肿瘤耐药的靶点及其应用
JP7720911B2 (ja) 2020-12-04 2025-08-08 ラボラトリオス シラネス、エセ．ア．デ セ．べ． 痛みに対するオピオイド鎮痛薬と抗てんかん薬のコーティングされた安定な固体医薬組成物
US11977085B1 (en) 2023-09-05 2024-05-07 Elan Ehrlich Date rape drug detection device and method of using same

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6057368A (en) * 1998-08-05 2000-05-02 Brookhaven Science Associates Llc Treatment of addiction and addiction-related behavior
US6541520B1 (en) * 1998-08-05 2003-04-01 Brookhaven Science Associates Treatment of addiction and addiction-related behavior

Also Published As

Publication number Publication date
BR0209613A (pt) 2004-12-07
PL368505A1 (en) 2005-04-04
EP1392301A4 (en) 2004-07-14
NZ529614A (en) 2006-08-31
WO2002091990A3 (en) 2003-03-27
DE60236927D1 (de) 2010-08-19
US6939876B2 (en) 2005-09-06
US20020187996A1 (en) 2002-12-12
YU89003A (sh) 2006-08-17
WO2002091990A2 (en) 2002-11-21
HUP0402326A3 (en) 2008-04-28
CN1531431A (zh) 2004-09-22
ATE473001T1 (de) 2010-07-15
CZ20033380A3 (cs) 2005-03-16
MXPA03010407A (es) 2004-05-05
US20030134868A1 (en) 2003-07-17
AU2002342533B2 (en) 2007-07-05
HRP20030892A2 (en) 2005-08-31
US20030004176A1 (en) 2003-01-02
IL158762A0 (en) 2004-05-12
NO331509B1 (no) 2012-01-16
ES2348637T3 (es) 2010-12-10
EP1392301B1 (en) 2010-07-07
HUP0402326A2 (hu) 2005-02-28
CN100528156C (zh) 2009-08-19
KR20040020054A (ko) 2004-03-06
CA2446639C (en) 2010-11-02
CA2446639A1 (en) 2002-11-21
JP2004534029A (ja) 2004-11-11
EP1392301A2 (en) 2004-03-03

Similar Documents

Publication Publication Date Title
WO2004091540A3 (en) Methods of treating pain and compositions for use therefor
WO2002038142A3 (en) Serotonergic compositions and methods for treatment of mild cognitive impairment
ATE320803T1 (de) Verfahren zur behandlung von alzheimerschen krankheit
MXPA05003501A (es) Metodos para tratamiento del dolor administrando un antagonista del factor de crecimiento del nervio y un analgesico opioide y composiciones que los contienen.
SI1509232T1 (sl) Kombinacija antagonista nmda in zaviralcev acetilholinesteraze za zdravljenje alzheimerjeve bolezni
AU2002302587A1 (en) Acne treatment with lipooxigenase inhibitors
WO2004105737A3 (en) Pharmaceutical compositions and methods relating to inhibiting fibrous adhesions using various agents
DE60128912D1 (en) Pyridoxin- und pyridoxalanaloga als cardiovasculäre therapeutika
EP1553951A4 (en) COMPOSITIONS CONTAINING A JNK INHIBITOR FOR TREATING, PREVENTING, MANAGING AND / OR MODIFYING PAIN, AND METHODS OF USE THEREOF
WO2001001972A3 (en) SELECTIVE iGluR5 RECEPTOR ANTAGONISTS FOR THE TREATMENT OF MIGRAINE
GB2405336A (en) Cholinesterase inhibitors to prevent injuries caused by chemicals
TW200507840A (en) Method of treating multiple myeloma
ZA200510170B (en) Method of reducing the harmful effects of orally or transdermally delivered nicotine
NO20035038D0 (no) Forhindring av avhengighet ved smertebehandling
WO2004028548A3 (en) Inhibitors of the nitrix oxide synthase iii (nos iii) as neuroprotective agents
TW200502234A (en) Pyridyloxymethyl and benzisoxazole azabicyclic derivatives
EP1262196A3 (en) Combination of a monoamine reuptake inhibitor and an opioid antagonist for use in alcoholism and alcohol dependence
AU5170400A (en) Topical application of muscarinic and opioid agents for treatment of tinnitus
EP1441718A4 (en) CARBINOL FOR THE TREATMENT OF NEUROPATHIC FUNCTIONAL DISORDER
WO1999065475A3 (en) Combination of phentolamine and apomorphine for the treatment of human sexual function and dysfunction
WO2005041886A3 (en) Methods for generating or increasing revenues related to pain inhibitor commerce
WO2007006732A8 (en) Synergistic combination for the treatment of pain (cannabioid receptor agonist and opiod receptor agonist)
MXPA04004075A (es) Compuesto y metodo para tratamiento de vejiga hiperactiva.
IL166596A0 (en) Salt of morphine-6-glucoronide
AU2003259198A8 (en) Method and composition for treating and preventing influenza infection and symptoms thereof

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees